Sumitomo Mitsui Trust Holdings, Inc. Novavax Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$36.28 - $75.29 $6.31 Million - $13.1 Million	-173,986 Reduced 97.55%	4,365 $224,000
Q1 2022 Apr 27, 2022	BUY	$69.73 - $142.9 $265,950 - $545,020	3,814 Added 2.19%	178,351 $13.1 Million
Q4 2021 Feb 02, 2022	SELL	$134.56 - $217.97 $836,155 - $1.35 Million	-6,214 Reduced 3.44%	174,537 $25 Million
Q3 2021 Oct 25, 2021	SELL	$177.8 - $270.58 $1.37 Million - $2.09 Million	-7,727 Reduced 4.1%	180,751 $37.5 Million
Q2 2021 Aug 02, 2021	BUY	$121.0 - $257.67 $22.8 Million - $48.6 Million	188,478 New	188,478 $40 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.